Genprex, Inc. 8-K Report: Key Insights for Investors - February 7, 2025

Here are the key insights extracted from the provided financial report section:

1. Company Information:

• Name: Genprex, Inc.
• State of Incorporation: Delaware (DE)
• CIK Number: 0001595248
• Address: 3300 Bee Cave Road #650-227, Austin, TX 78746
• Contact Number: 512-537-7997

2. SEC Filing Details:

• Filing Type: 8-K (Current Report)
• Filing Date: February 7, 2025
• SEC File Number: 001-38244
• Tax Identification Number: 90-0772347

3. Stock Information:

• Common Stock Symbol: GNPX
• Stock Exchange: NASDAQ

4. Reporting Period:

• Start Date: February 7, 2025
• End Date: February 7, 2025

5. XBRL Information:

• The document is structured in XBRL format for regulatory compliance, indicating adherence to SEC reporting standards.

Insights:

• The filing indicates that Genprex, Inc. is actively reporting to the SEC, which is essential for transparency with investors.
• The specific reporting date suggests that the information might pertain to a significant event occurring on that date, requiring immediate disclosure.
• The choice of an 8-K filing implies that the company may be reporting material events that shareholders need to be aware of.

This information is crucial for investors, analysts, and stakeholders to assess the company's current operational status and any significant developments.